Olivier Rouaud
Overview
Explore the profile of Olivier Rouaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baumgartner T, Di Liberto G, Loser V, Vicino A, Theaudin M, Castro-Jimenez M, et al.
Rev Med Suisse
. 2025 Jan;
21(900-1):59-62.
PMID: 39812289
In 2024, therapeutic and diagnostic advancements are shaping the field of neurology. Three new drugs show promise for treating myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. A new classification for...
2.
Meyer R, Monsch A, Allali G, Barro-Belaygues N, Becker S, Burge M, et al.
Praxis (Bern 1994)
. 2024 Dec;
113(11-12):293-296.
PMID: 39697156
The possible authorisation of new monoclonal antibody therapies for Alzheimer's disease poses challenges for healthcare systems worldwide. In this paper, the Swiss Memory Clinics association (SMC) analyses the available resources...
3.
Pozuelo Moyano B, Zullo L, Rouaud O, Vandel P, von Gunten A, Allali G
Neurodegener Dis
. 2024 Dec;
1-14.
PMID: 39647472
No abstract available.
4.
Lalive H, Griffa A, Carlier S, Nasuti M, Di Noto T, Marechal B, et al.
J Alzheimers Dis
. 2024 Jun;
100(1):333-343.
PMID: 38875037
Background: Amnestic syndrome of the hippocampal type (ASHT) in Memory Clinics is a presentation common to Alzheimer's disease (AD). However, ASHT can be found in other neurodegenerative disorders. Objective: To...
5.
Putallaz P, Seematter-Bagnoud L, Draganski B, Rouaud O, Krief H, Bula C
BMC Geriatr
. 2024 May;
24(1):427.
PMID: 38745127
Background: Tight diabetes control is often applied in older persons with neurocognitive disorder resulting in increased hypoglycemic episodes but little is known about the pattern of brain injury in these...
6.
Chiabotti P, Rouaud O, Allali G
Neurology
. 2024 Apr;
102(9):e209375.
PMID: 38648577
No abstract available.
7.
Nwamekang Belinga L, Espourteille J, Wepnyu Njamnshi Y, Zafack Zeukang A, Rouaud O, Njamnshi A, et al.
Neurodegener Dis
. 2024 Mar;
24(1):26-40.
PMID: 38555638
Background: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African...
8.
Pizzarotti B, Buhler-Heintze A, Allali G, Rouaud O, Bally J, Michel P, et al.
Rev Med Suisse
. 2024 Jan;
20(856-7):72-75.
PMID: 38231105
The year 2023 is marked by the arrival on the market of lecanemab for the treatment of Alzheimer's disease. New biomarkers have demonstrated their usefulness in monitoring peripheral neuropathies and...
9.
Pozuelo Moyano B, Salvioni P, Zullo L, Rouaud O, von Gunten A, Girardin F, et al.
Alzheimers Dement
. 2023 Aug;
19(12):5847-5848.
PMID: 37587609
No abstract available.
10.
Vandersteen C, Plonka A, Manera V, Sawchuk K, Lafontaine C, Galery K, et al.
Front Aging Neurosci
. 2023 Jul;
15:1206123.
PMID: 37416323
Introduction: The risk of developing Alzheimer's disease (AD) in older adults increasingly is being discussed in the literature on Post-Acute COVID-19 Syndrome (PACS). Remote digital Assessments for Preclinical AD (RAPAs)...